BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20736346)

  • 1. Activating stress-activated protein kinase-mediated cell death and inhibiting epidermal growth factor receptor signaling: a promising therapeutic strategy for prostate cancer.
    Kumar R; Srinivasan S; Pahari P; Rohr J; Damodaran C
    Mol Cancer Ther; 2010 Sep; 9(9):2488-96. PubMed ID: 20736346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting TNF-mediated signaling: a novel therapeutic paradigm for androgen independent prostate cancer.
    Srinivasan S; Kumar R; Koduru S; Chandramouli A; Damodaran C
    Apoptosis; 2010 Feb; 15(2):153-61. PubMed ID: 19851870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A; Agarwal R; Agarwal C
    Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoralidin, an herbal molecule, inhibits phosphatidylinositol 3-kinase-mediated Akt signaling in androgen-independent prostate cancer cells.
    Kumar R; Srinivasan S; Koduru S; Pahari P; Rohr J; Kyprianou N; Damodaran C
    Cancer Prev Res (Phila); 2009 Mar; 2(3):234-43. PubMed ID: 19223576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Carmustine and Selenite Inhibits EGFR Mediated Growth Signaling in Androgen-Independent Prostate Cancer Cells.
    Thamilselvan V; Menon M; Stein GS; Valeriote F; Thamilselvan S
    J Cell Biochem; 2017 Dec; 118(12):4331-4340. PubMed ID: 28430389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer.
    Liao Y; Guo Z; Xia X; Liu Y; Huang C; Jiang L; Wang X; Liu J; Huang H
    J Exp Clin Cancer Res; 2019 Apr; 38(1):157. PubMed ID: 30975171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways.
    Kraus S; Levy G; Hanoch T; Naor Z; Seger R
    Cancer Res; 2004 Aug; 64(16):5736-44. PubMed ID: 15313914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inositol hexaphosphate downregulates both constitutive and ligand-induced mitogenic and cell survival signaling, and causes caspase-mediated apoptotic death of human prostate carcinoma PC-3 cells.
    Gu M; Raina K; Agarwal C; Agarwal R
    Mol Carcinog; 2010 Jan; 49(1):1-12. PubMed ID: 19544333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase.
    Singh SV; Choi S; Zeng Y; Hahm ER; Xiao D
    Cancer Res; 2007 Aug; 67(15):7439-49. PubMed ID: 17671214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C-{alpha} mediates epidermal growth factor receptor transactivation in human prostate cancer cells.
    Stewart JR; O'Brian CA
    Mol Cancer Ther; 2005 May; 4(5):726-32. PubMed ID: 15897236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of Glutathione S-Transferase P1 (GSTP1) by Epidermal Growth Factor Receptor (EGFR) Promotes Formation of the GSTP1-c-Jun N-terminal kinase (JNK) Complex and Suppresses JNK Downstream Signaling and Apoptosis in Brain Tumor Cells.
    Okamura T; Antoun G; Keir ST; Friedman H; Bigner DD; Ali-Osman F
    J Biol Chem; 2015 Dec; 290(52):30866-78. PubMed ID: 26429914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C.
    Li J; Xiang S; Zhang Q; Wu J; Tang Q; Zhou J; Yang L; Chen Z; Hann SS
    J Exp Clin Cancer Res; 2015 May; 34(1):46. PubMed ID: 25971429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells.
    Kue PF; Taub JS; Harrington LB; Polakiewicz RD; Ullrich A; Daaka Y
    Int J Cancer; 2002 Dec; 102(6):572-9. PubMed ID: 12447997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells.
    Sen A; O'Malley K; Wang Z; Raj GV; Defranco DB; Hammes SR
    J Biol Chem; 2010 Sep; 285(37):28787-95. PubMed ID: 20628053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa).
    Barnes CJ; Bagheri-Yarmand R; Mandal M; Yang Z; Clayman GL; Hong WK; Kumar R
    Mol Cancer Ther; 2003 Apr; 2(4):345-51. PubMed ID: 12700278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.
    Wu CJ; Qian X; O'Rourke DM
    DNA Cell Biol; 1999 Oct; 18(10):731-41. PubMed ID: 10541432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line.
    Yoon JH; Higuchi H; Werneburg NW; Kaufmann SH; Gores GJ
    Gastroenterology; 2002 Apr; 122(4):985-93. PubMed ID: 11910351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type II cGMP-dependent protein kinase inhibits EGF-induced MAPK/JNK signal transduction in breast cancer cells.
    Lan T; Chen Y; Sang J; Wu Y; Wang Y; Jiang L; Tao Y
    Oncol Rep; 2012 Jun; 27(6):2039-44. PubMed ID: 22427012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
    Lee YF; Lin WJ; Huang J; Messing EM; Chan FL; Wilding G; Chang C
    Cancer Res; 2002 Nov; 62(21):6039-44. PubMed ID: 12414626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.